Discovery of novel antileishmanial agents in an attempt to synthesize pentamidine-aplysinopsin hybrid molecule.
Sharad Porwal, Shikha S Chauhan, Prem M S Chauhan, Nishi Shakya, Aditya Verma, Suman Gupta
Index: J. Med. Chem. 52 , 5793-802, (2009)
Full Text: HTML
Abstract
In an attempt to synthesize pentamidine-aplysinopsin hybrid molecule 25, a lead molecule 8 (containing Z-configured aplysinopsin moiety) was identified for antileishmanial activity. Optimization of lead 8 provided 24 (containing E-configured aplysinopsin) possessing 10 times more activity and 401-fold less toxicity than the drug pentamidine in cell based assays. Synthesis of 24 was possible, surprisingly, because of two innate reactivities of indole-3-carbaldehyde which provided it in diastereo- and regio-selectively pure form without recourse to the long reaction pathway.
Related Compounds
Related Articles:
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2014-01-01
[Leuk. Res. 38(1) , 49-56, (2014)]
In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
2013-09-01
[Exp. Parasitol. 135(1) , 36-41, (2013)]
Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.
2015-04-01
[Antimicrob. Agents Chemother. 59 , 2037-44, (2015)]
2014-01-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 998-999 , 57-62, (2015)]